You have 9 free searches left this month | for more free features.

Etoposide

Showing 1 - 25 of 1,594

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Extensive Stage Small Cell Lung Cancer Trial (HLX10 + chemo (carboplatin-etoposide), Atezolizumab + chemo

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • HLX10 + chemotherapy (carboplatin-etoposide)
  • Atezolizumab + chemotherapy (carboplatin-etoposide)
  • (no location specified)
Jul 19, 2022

Glioblastoma Multiforme Trial in Edmonton (Tamoxifen, Etoposide)

Recruiting
  • Glioblastoma Multiforme
  • Edmonton, Alberta, Canada
    Cross Cancer Institute
Mar 28, 2022

Hemophagocytic Lymphohistiocytosis Trial in Beijing (Venetoclax, Dexamethasone, Etoposide)

Recruiting
  • Hemophagocytic Lymphohistiocytosis
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Sep 15, 2022

Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

Recruiting
  • Neuroblastoma in Children
  • Tucidinostat and etoposide
  • Guangzhou, China
    Sun Yat-sen University
Jun 9, 2022

Small Cell Lung Cancer Trial in North Bethesda (ETOPOSIDE - Usual, ETOPOSIDE - Study)

Active, not recruiting
  • Small Cell Lung Cancer
  • ETOPOSIDE - Usual
  • ETOPOSIDE - Study
  • North Bethesda, Maryland
    Medicine Invention Design, Inc. (MIDI) - IORG0007849
Aug 30, 2021

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Recurrent Medulloblastoma Trial in Beijing (Apatinib Combined With Temozolomide and Etoposide Capsules)

Recruiting
  • Recurrent Medulloblastoma
  • Apatinib Combined With Temozolomide and Etoposide Capsules
  • Beijing, China
    Beijing Sanbo Brain Hospital
Feb 10, 2022

Leukemia Trial in Houston (Alemtuzumab, Etoposide, Dexamethasone)

Active, not recruiting
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 2, 2022

Brain Tumor Recurrent Trial in Houston (Methotrexate, Etoposide, Ommaya Reservoir)

Recruiting
  • Brain Tumor Recurrent
  • Houston, Texas
    UTHealth & Children's Memorial Hermann Hospital
Aug 17, 2022

Germ Cell Tumor, Non-seminomatous Germ Cell Tumor, Ovarian Germ Cell Tumor Trial in Indianapolis (Etoposide)

Recruiting
  • Germ Cell Tumor
  • +2 more
  • Etoposide
  • Indianapolis, Indiana
    Indiana University Melvin & Bren Simon Cancer Center
Feb 23, 2022

Hematological Malignancy Trial in Ningbo (Etoposide, Cytarabine, PEG-rhG-CSF)

Recruiting
  • Hematological Malignancy
  • Etoposide
  • +2 more
  • Ningbo, Zhejiang, China
    The Affiliated People's Hospital of Ningbo University.
Aug 18, 2022

Acute Myeloid Leukemia Trial in Pittsburgh (mitoxantrone + etoposide + gemtuzumab ozogamicin)

Recruiting
  • Acute Myeloid Leukemia
  • mitoxantrone + etoposide + gemtuzumab ozogamicin
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 9, 2022

Small Cell Neuroendocrine Carcinoma of Bladder, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore

Recruiting
  • Small Cell Neuroendocrine Carcinoma of Bladder
  • +2 more
  • Washington, District of Columbia
  • +1 more
Jun 27, 2022

Triple Negative Breast Cancer Trial in Beijing (oral etoposide + anlotinib)

Recruiting
  • Triple Negative Breast Cancer
  • oral etoposide + anlotinib
  • Beijing, China
    Cancer Institute & Hospital. Chinese Academy of Medical Sciences
Jul 15, 2021

DLBCL (DLBCL) Trial (Glofitamab, Obinutuzumab, Tocilizumab)

Not yet recruiting
  • Diffuse Large B-Cell Lymphoma (DLBCL)
  • (no location specified)
Jul 31, 2022

Extensive Stage Small Cell Lung Cancer Trial (Tarlatamab, Carboplatin, Etoposide)

Not yet recruiting
  • Extensive Stage Small Cell Lung Cancer
  • (no location specified)
Aug 19, 2022

Extensive-stage Small-cell Lung Cancer Trial in Shanghai (ZKAB001, Placebo, Carboplatin)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • ZKAB001
  • +3 more
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Sep 8, 2021

Ovarian Cancer Trial in Beijing, Jinan (Niraparib)

Recruiting
  • Ovarian Cancer
  • Beijing, China
  • +1 more
Aug 27, 2021

Small Cell Lung Cancer Trial in Nice (acetazolamide in combination with platinum and etoposide-based radiochemo)

Recruiting
  • Small Cell Lung Cancer
  • acetazolamide in combination with platinum and etoposide-based radiochemotherapy
  • Nice, France
    Centre Antoine Lacassagne
Jan 11, 2022

SCLC, Extensive Stage Trial in Zhengzhou (Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive

Not yet recruiting
  • SCLC, Extensive Stage
  • Alotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung Cancer
  • (no location specified)
Aug 2, 2021

Extensive-stage Small-cell Lung Cancer Trial in Hangzhou (QL1706, Carboplatin, Etoposide)

Recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jul 13, 2022

Leukemia, MDS Trial (drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • Myelodysplastic Syndromes
  • (no location specified)
Feb 17, 2022

Lymphoma Trial in Duarte (drug, other, procedure)

Active, not recruiting
  • Lymphoma
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Extensive-stage Small-cell Lung Cancer Trial in Pittsburgh (Durvalumab 50 MG/1 ML Intravenous Solution, Etoposide Injection,

Not yet recruiting
  • Extensive-stage Small-cell Lung Cancer
  • Durvalumab 50 MG/1 ML Intravenous Solution
  • +4 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
May 31, 2022

DLBCL Trial in Qingdao (Selinexor combined with Prednisone, Etoposide, and Lenalidomide)

Not yet recruiting
  • DLBCL
  • Selinexor combined with Prednisone, Etoposide, and Lenalidomide
  • Qingdao, Shandong, China
    the affiliated hospital of Qingdao University
Aug 18, 2022